Applicant, as named in the Orange Book

Nuvation

Next listed expiry: Ibtrozi on 3 Jun 2033. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ibtrozi taletrectinib adipate	taletrectinib adipate	219713	3 Jun 2033	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.